Sorafenib/sunitinib/temsirolimusVarious toxicities: 19 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1345卷 / 1期

关键词：

Heart Failure; Patient Outcome; Renal Cell Carcinoma; Renal Cell; Partial Response;

D O I：

10.2165/00128415-201113450-00097

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：29 / 29

相关论文

共 50 条

[31] CorticotropinVarious toxicities: 19 case reports
Reactions Weekly, 2023, 1938 (1) : 442 - 442
[32] AntitubercularsVarious toxicities: 19 case reports
Reactions Weekly, 2017, 1673 (1) : 59 - 59
[33] Sorafenib/sunitinib withdrawalSymptom flare in renal cell carcinoma: 3 case reports
Reactions Weekly, 2010, 1288 (1) : 36 - 36
[34] Iodine-radioactive/sorafenib/vandetanibVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1742 (1) : 131 - 131
[35] Sorafenib/yttrium-90Various toxicities: 2 case reports
Reactions Weekly, 2015, 1537 (1) : 234 - 234
[36] Multiple drugsVarious toxicities: 19 case reports
Reactions Weekly, 2019, 1747 (1) : 194 - 194
[37] Multiple drugsVarious toxicities: 19 case reports
Reactions Weekly, 2020, 1826 (1) : 241 - 241
[38] Atezolizumab/nivolumabVarious toxicities: 19 case reports
Reactions Weekly, 2018, 1730 (1) : 60 - 60
[39] Multiple drugsVarious toxicities: 19 case reports
Reactions Weekly, 2022, 1910 (1) : 357 - 357
[40] Adalimumab/infliximabVarious toxicities: 19 case reports
Reactions Weekly, 2015, 1573 (1) : 22 - 22

← 1 2 3 4 5 →